Application 063038
- Type
- ANDA
- Sponsor
- PERRIGO NEW YORK
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ERYTHROMYCIN | ERYTHROMYCIN | SOLUTION;TOPICAL | 2% | No | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 45802-038 | erythromycin | erythromycin | Padagis Israel Pharmaceuticals Ltd | ANDA | Current |
| 45802-038 | erythromycin | erythromycin | Padagis Israel Pharmaceuticals Ltd | ANDA | Current |
| 45802-038 | erythromycin | erythromycin | Perrigo New York Inc | ANDA | Current |
| 45802-038 | erythromycin | erythromycin | Perrigo New York Inc | ANDA | Current |
| 68071-4791 | erythromycin | erythromycin | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-4791 | erythromycin | erythromycin | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-4791 | erythromycin | erythromycin | NuCare Pharmaceuticals,Inc. | ANDA | Current |